Search

Author/Creator Wang, Shu-Yuan

1. A non-linear association between blood tumor mutation burden and prognosis in NSCLC patients receiving atezolizumab. (1st January 2020)

Authors:
Nie, Wei; Qian, Jie; Xu, Mi-Die; Gu, Kai; Qian, Fang-Fei; Hu, Min-Juan; Lu, Jun; Gan, Lu; Zhang, Xue-Yan; Cao, Shu-Hui; Li, Jing-Wen; Wang, Yue; Zhang, Bo; Wang, Shu-Yuan; Hu, Fang; Li, Chang-Hui; Zhong, Hua; Han, Bao-Hui
Journal:
Oncoimmunology
Issue:
Volume 9:Number 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Advanced Non–Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy. Issue 6 (July 2020)

Authors:
Nie, Wei; Xu, Mi-Die; Gan, Lu; Zhang, Yi; Qian, Jie; Gu, Kai; Zhang, Xue-Yan; Wang, Hui-Min; Yan, Bo; Gu, Ping; Zhang, Bo; Wang, Shu-Yuan; Hu, Fang; Li, Chang-Hui; Zhong, Hua; Han, Bao-Hui
Journal:
Journal of immunotherapy
Issue:
Volume 43:Issue 6(2020:Jul./Aug.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation. (1st January 2021)

Authors:
Nie, Wei; Gan, Lu; Wang, Xin; Gu, Kai; Qian, Fang-Fei; Hu, Min-Juan; Zhang, Ding; Chen, Shi-Qing; Lu, Jun; Cao, Shu-Hui; Li, Jing-Wen; Wang, Yue; Zhang, Bo; Wang, Shu-Yuan; Li, Chang-Hui; Yang, Ping; Xu, Mi–Die; Zhang, Xue-Yan; Zhong, Hua; Han, Bao-Hui
Journal:
Oncoimmunology
Issue:
Volume 10:Number 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗